195 related articles for article (PubMed ID: 11712747)
21. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
[TBL] [Abstract][Full Text] [Related]
22. CCR3 blockade as a new therapy for asthma.
Bertrand CP; Ponath PD
Expert Opin Investig Drugs; 2000 Jan; 9(1):43-52. PubMed ID: 11060659
[TBL] [Abstract][Full Text] [Related]
23. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system.
Ferland C; Guilbert M; Davoine F; Flamand N; Chakir J; Laviolette M
J Leukoc Biol; 2001 May; 69(5):772-8. PubMed ID: 11358986
[TBL] [Abstract][Full Text] [Related]
24. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch.
Benarafa C; Collins ME; Hamblin AS; Cunningham FM
Vet Rec; 2002 Dec; 151(23):691-3. PubMed ID: 12503787
[TBL] [Abstract][Full Text] [Related]
25. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
[TBL] [Abstract][Full Text] [Related]
26. Expression of the chemokine eotaxin and its receptor, CCR3, in human endometrium.
Zhang J; Lathbury LJ; Salamonsen LA
Biol Reprod; 2000 Feb; 62(2):404-11. PubMed ID: 10642580
[TBL] [Abstract][Full Text] [Related]
27. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
Erin EM; Williams TJ; Barnes PJ; Hansel TT
Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):201-14. PubMed ID: 14561201
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
Ponath PD; Qin S; Post TW; Wang J; Wu L; Gerard NP; Newman W; Gerard C; Mackay CR
J Exp Med; 1996 Jun; 183(6):2437-48. PubMed ID: 8676064
[TBL] [Abstract][Full Text] [Related]
29. Airway hyperresponsiveness: first eosinophils and then neuropeptides.
Kraneveld AD; Folkerts G; Van Oosterhout AJ; Nijkamp FP
Int J Immunopharmacol; 1997; 19(9-10):517-27. PubMed ID: 9637348
[TBL] [Abstract][Full Text] [Related]
30. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
31. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
32. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells.
Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB
Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841
[TBL] [Abstract][Full Text] [Related]
34. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin.
Gao JL; Sen AI; Kitaura M; Yoshie O; Rothenberg ME; Murphy PM; Luster AD
Biochem Biophys Res Commun; 1996 Jun; 223(3):679-84. PubMed ID: 8687456
[TBL] [Abstract][Full Text] [Related]
35. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
36. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
[TBL] [Abstract][Full Text] [Related]
37. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
38. Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.
Kudlacz EM; Whitney CA; Andresen CJ; Umland JP; Cheng JB
Br J Pharmacol; 1999 Oct; 128(3):788-94. PubMed ID: 10516663
[TBL] [Abstract][Full Text] [Related]
39. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
[TBL] [Abstract][Full Text] [Related]
40. Cytokines, chemokines, RANTES, and eotaxin.
Graziano FM; Cook EB; Stahl JL
Allergy Asthma Proc; 1999; 20(3):141-6. PubMed ID: 10389546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
